September 18, 2026

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A Look at Its 95.76% Potential Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a cutting-edge biotechnology firm specializing in genome editing, offers intriguing possibilities for investors focused on the healthcare sector. With its headquarters in Cambridge, Massachusetts, Intellia..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A 50% Upside Potential Amidst Robust Revenue Growth

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), an innovative player in the healthcare sector, is attracting investor attention with its promising growth prospects. Specializing in developing therapies for chronic endocrine and..

Auna SA (AUNA) Stock Analysis: Exploring a Compelling 35.91% Potential Upside

Auna SA (AUNA), a prominent player in the healthcare sector with operations spanning Mexico, Peru, and Colombia, presents an intriguing proposition for investors seeking promising growth in medical care facilities...

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Navigating a Potential 7.54% Upside in the Biotech Arena

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of the biotechnology sector, focusing its efforts on developing innovative therapeutics for infectious diseases. Headquartered in Warminster, Pennsylvania, Arbutus is a..

Iovance Biotherapeutics (IOVA) Stock Analysis: Unpacking the 65.7% Revenue Growth Potential

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands at the forefront of the biotechnology sector, captivating investors with its promising advancements in cell therapy for cancer treatment. With a market capitalization of..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating Healthcare Tech with a 15.5% Revenue Growth

Weave Communications, Inc. (NYSE: WEAV) is making waves in the healthcare technology sector with its innovative AI-driven solutions for patient communication and engagement. Headquartered in Lehi, Utah, Weave Communications is..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring the 90.27% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), operating within the dynamic healthcare sector, is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic products to combat serious infectious diseases. The company, founded..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 118% Potential Upside Beckons Investors

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, is garnering significant attention from investors, driven by its potential upside of 118.31%. With a market capitalization of..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a Potential 281% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm based in Waltham, Massachusetts, is attracting significant attention from investors seeking opportunities in the healthcare sector. Specializing in the discovery and commercialization of..

Rocket Pharmaceuticals, Inc. (RCKT)

⚠️ No article content returned.

..

Claritev Corporation (CTEV) Stock Analysis: Unpacking a 44.45% Upside Potential in Healthcare Innovation

Claritev Corporation (CTEV), a notable player in the healthcare sector, is making waves with its comprehensive suite of data analytics and technology-enabled solutions. Headquartered in McLean, Virginia, Claritev specializes in..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Navigating the Biotech Seas with Strategic Collaborations

For investors eyeing the dynamic healthcare sector, Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a fascinating proposition within the biotechnology industry. With a market capitalization of approximately $884.7 million, this South..

Arcus Biosciences (RCUS) Stock Analysis: Exploring a 51.72% Potential Upside in Biotechnology

Arcus Biosciences, Inc. (NASDAQ: RCUS) stands as a compelling player in the biotechnology sector, capturing investor interest with a notable potential upside of 51.72% according to analyst ratings. With a..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A 19.63% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) is capturing the attention of investors with its promising growth potential in the healthcare sector. Specializing in molecular diagnostics, the company offers innovative solutions for..

Corero expands cybersecurity offering as sales strategy takes hold

Corero is broadening its cybersecurity portfolio and sales channels as higher order activity begins to translate into stronger revenue and earnings capacity...

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a Potential 68% Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), a clinical-stage biotechnology firm, is becoming an intriguing prospect for investors seeking exposure in the healthcare sector, particularly within biotechnology. With a robust market capitalization..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Potential 47.69% Upside in the Oncology Device Market

Delcath Systems, Inc. (DCTH), a healthcare player specializing in medical devices, has been gaining investor attention due to its innovative approach in the treatment of liver cancers. With a strategic..

Zenas BioPharma, Inc. (ZBIO): Analyst Ratings Suggest a 47% Upside in Biotech Investment

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is capturing investor attention with its promising pipeline of immunology-based therapies. With a market capitalization of $2.08..

LENZ Therapeutics, Inc. (LENZ): Analyzing the Potential 481% Upside for Investors

Investors with a keen eye on the biotechnology sector might find LENZ Therapeutics, Inc. (NASDAQ: LENZ) a compelling opportunity. With its current market cap of $129.77 million, the company is..

Capricor Therapeutics (CAPR) Stock Analysis: Unpacking a 186.62% Potential Upside in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology player, has captured the attention of investors with its promising pipeline and substantial potential upside. Operating in the healthcare sector and specializing..

Search

Funds

September 18, 2026

Corero expands cybersecurity offering as sales strategy takes hold

Corero is broadening its cybersecurity portfolio and sales channels as higher order activity begins to translate into stronger revenue and earnings capacity...
Search

Funds

September 18, 2026

FTSE 100

Funds